NOTR Stock Overview

Distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses. More details

NOTR fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Revenue grew by 731.2% over the past year

Risk Analysis

Shares are highly illiquid

Has less than 1 year of cash runway

Makes less than USD$1m in revenue ($843K)

Does not have a meaningful market cap ($42M)

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Nowtransit Inc. Competitors

Kun Peng International

OTCPK:KPEA

US$28.8m

Hong Kong Pharma Digital Technology Holdings

NasdaqCM:HKPD

US$24.4m

Cosmos Health

NasdaqCM:COSM

US$14.7m

Agape ATP

NasdaqCM:ATPC

US$5.8m

Price History & Performance

Summary of share price highs, lows and changes for Nowtransit
Historical stock prices
Current Share Price	US$1.00
52 Week High	US$1.00
52 Week Low	US$1.00
Beta	0.48
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-68.94%
5 Year Change	n/a
Change since IPO	81.82%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NOTR	US Healthcare	US Market
7D	0%	3.5%	-0.8%
1Y	n/a	-0.07%	25.2%

Return vs Industry: Insufficient data to determine how NOTR performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how NOTR performed against the US Market.

Price Volatility

Is NOTR's price volatile compared to industry and market?
NOTR volatility
NOTR Average Weekly Movement	n/a
Healthcare Industry Average Movement	8.0%
Market Average Movement	6.5%
10% most volatile stocks in US Market	18.7%
10% least volatile stocks in US Market	3.3%

Stable Share Price: NOTR has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NOTR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Darren Lopez	n/a

Nowtransit Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin; TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac and niacinamide; and Metabolism+ to enhance metabolism. It sells its products through Amazon platform; wholesales through online platform; private label sales; and direct sales.

Nowtransit Inc. Fundamentals Summary

How do Nowtransit's earnings and revenue compare to its market cap?
NOTR fundamental statistics
Market cap	US$41.60m
Earnings (TTM)	-US$234.16k
Revenue (TTM)	US$842.86k

49.4x

P/S Ratio

-177.6x

P/E Ratio

Is NOTR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NOTR income statement (TTM)
Revenue	US$842.86k
Cost of Revenue	US$151.28k
Gross Profit	US$691.58k
Other Expenses	US$925.74k
Earnings	-US$234.16k

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0056
Gross Margin	82.05%
Net Profit Margin	-27.78%
Debt/Equity Ratio	29.4%

How did NOTR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/07/08 18:41
End of Day Share Price	2024/04/10 00:00
Earnings	2024/03/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nowtransit Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution